Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?

Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)? Publisher Pubmed

Shahididadras M¹ ; Tabary M² ; Robati RM^{1, 3} ; Araghi F¹ ; Dadkhahfar S¹

Show Affiliations

1. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Dermatology, Laghman Hakim Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran

Source: Journal of Dermatological Treatment Published:2022

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)

2. A Theoretical Strategy for Acceleration of Human Immune Response Against Sars-Cov-2: A Fusion Protein Harboring Virus-Binding and Pre-Exposed Antigen Domains, VirusDisease (2021)

3. A Comprehensive Review on Covid-19 Infection and Comorbidities of Various Organs, Acta Medica Iranica (2021)

4. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)

5. Design of Novel Disturbing Peptides Against Ace2 Sars-Cov-2 Spike-Binding Region by Computational Approaches, Frontiers in Pharmacology (2022)

6. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)

7. Potential Use of Angiotensin Receptor Blockers in Skin Pathologies, Iranian Journal of Basic Medical Sciences (2023)

8. Binder Design for Targeting Sars-Cov-2 Spike Protein: An in Silico Perspective, Gene Reports (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (1)

Mohammadali Ali Mazloumi (1)

Style	Citing Format
MLA	Shahididadras M, et al.. "Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?." Journal of Dermatological Treatment, vol. 33, no. 2, 2022, pp. 1175-1176.
APA	Shahididadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S (2022). Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?. Journal of Dermatological Treatment, 33(2), 1175-1176.
Chicago	Shahididadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S. "Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?." Journal of Dermatological Treatment 33, no. 2 (2022): 1175-1176.
Harvard	Shahididadras M et al. (2022) 'Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?', Journal of Dermatological Treatment, 33(2), pp. 1175-1176.
Vancouver	Shahididadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S. Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?. Journal of Dermatological Treatment. 2022;33(2):1175-1176.
BibTex	@article{ author = {Shahididadras M and Tabary M and Robati RM and Araghi F and Dadkhahfar S}, title = {Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)?}, journal = {Journal of Dermatological Treatment}, volume = {33}, number = {2}, pages = {1175-1176}, year = {2022} }
RIS	TY - JOUR AU - Shahididadras M AU - Tabary M AU - Robati RM AU - Araghi F AU - Dadkhahfar S TI - Psoriasis and Risk of the Covid-19: Is There a Role for Angiotensin Converting Enzyme (Ace)? JO - Journal of Dermatological Treatment VL - 33 IS - 2 SP - 1175 EP - 1176 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract